Immunomedics, Inc. (IMMU): Price and Financial Metrics
Today's Latest Price: $85.25 USD
Sep 29 4:00pm Add IMMU to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
IMMU Stock Summary The ratio of debt to operating expenses for Immunomedics Inc is higher than it is for about only 6.28% of US stocks. IMMU's price/sales ratio is 970.46; that's higher than the P/S ratio of 99.4% of US stocks. Revenue growth over the past 12 months for Immunomedics Inc comes in at 6,804.75%, a number that bests 99.79% of the US stocks we're tracking. If you're looking for stocks that are quantitatively similar to Immunomedics Inc, a group of peers worth examining would be ZLAB, LIFE, ITCI, CBMG, and CANF. IMMU's SEC filings can be seen here. And to visit Immunomedics Inc's official web site, go to www.immunomedics.com.
IMMU Price/Volume Stats
Immunomedics, Inc. (IMMU) Company Bio
Immunomedics, Inc. focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. The company was founded in 1982 and is based in Morris Plains, New Jersey.
IMMU Latest News Stream
All News Types
Commentary Corp. News Cramer Debt Offering Downgrade Earnings Mgmt Change New Coverage (Bullish) Product News PT Lowered PT Raised Rating Reiterated (Bullish) Stock Offering Upgrade
Loading, please wait...
Latest IMMU News From Around the Web
Below are the latest news stories about Immunomedics Inc that investors may wish to consider to help them evaluate IMMU as an investment opportunity.
Trodelvy. Source: Fierce Pharma Gilead (GILD) just unpacked part of its $21 billion war chest to acquire Immunomedics (IMMU) for $21 billion. "The agreement will provide Gilead with TrodelvyTM (sacituzumab govitecan-hziy), a first-in-class Trop-2 directed antibody-drug conjugate ((ADC)) that was granted accelerated approval by the U.S. Food and Drug Administration...
NEW YORK, NY / ACCESSWIRE / September 26, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Cellular Biomedicine Group, Inc.
Montage Resources Corporation
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
These are the healthcare stocks with the best value, fastest growth, and most momentum for October 2020.
Read More 'IMMU' Stories Here
IMMU Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7779 seconds.